Seven or less Fractions is Not the Standard of Care for Intermediate-Risk Prostate Cancer

A C Tree; D P Dearnaley

doi:10.1016/j.clon.2019.10.006

Seven or less Fractions is Not the Standard of Care for Intermediate-Risk Prostate Cancer

Clin Oncol (R Coll Radiol). 2020 Mar;32(3):175-180. doi: 10.1016/j.clon.2019.10.006. Epub 2019 Nov 8.

Authors

A C Tree¹, D P Dearnaley²

Affiliations

¹ The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK. Electronic address: alison.tree@icr.ac.uk.
² The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK.

PMID: 31711737
DOI: 10.1016/j.clon.2019.10.006

Abstract

Evidence is accumulating for seven and less fractions in localised prostate cancer, including one large randomised trial. However, there is much more evidence yet to come and changing practice in advance of this may be premature. We review the reasons to persist with moderate hypofractionation for prostate cancer radiotherapy, until the results of further phase III studies are known.

Keywords: Moderate hypofractionation; prostate cancer; radiotherapy.

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Humans
Male
Prostatic Neoplasms / radiotherapy*
Radiation Dose Hypofractionation
Standard of Care*

Abstract

Publication types

MeSH terms

Grants and funding